Argenx Se (ARGX) Other Non-Current Assets (2016 - 2025)

Argenx Se (ARGX) posted Other Non-Current Assets of $52.0 million for Q4 2025, down 99.89% on a QoQ basis from $46.7 billion in Q2 2025, and up 22.64% year-over-year from $42.4 million in Q4 2024.

Argenx Se (ARGX) Other Non-Current Assets (2016 - 2025) Analysis & Trends

Argenx Se's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $52.0 million for Q4 2025.

  • Quarterly Other Non-Current Assets rose 22.64% year-over-year to $52.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52.0 million (up 22.64% YoY) and the FY2025 annual result came in at $52.0 million, up 22.64% from the prior year.
  • Other Non-Current Assets was $52.0 million for Q4 2025 at Argenx Se, down from $46.7 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $46.7 billion in Q2 2025 and bottomed at $1.4 million in Q2 2021.
  • A 5-year average of $4.7 billion and a median of $41.6 million in 2022 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets declined 25.48% — and 2025, when it surged 136097.34%.
  • Argenx Se's Other Non-Current Assets stood at $54.9 million in 2021, then dropped by 25.48% to $40.9 million in 2022, then dropped by 3.01% to $39.7 million in 2023, then advanced by 6.89% to $42.4 million in 2024, then gained by 22.64% to $52.0 million in 2025.
  • Business Quant data shows ARGX's Other Non-Current Assets at $52.0 million in Q4 2025, $46.7 billion in Q2 2025, and $42.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1.02 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 14.48 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 63.55 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 51.99 Mn
Jun 30, 2025 46.68 Bn
Dec 31, 2024 42.39 Mn
Jun 30, 2024 34.28 Mn
Dec 31, 2023 39.66 Mn
Jun 30, 2023 39.23 Mn
Dec 31, 2022 40.89 Mn
Jun 30, 2022 43.10 Mn
Dec 31, 2021 54.88 Mn
Jun 30, 2021 1.44 Mn
Dec 31, 2020 1.48 Mn
Jun 30, 2020 696,122.80
Dec 31, 2019 697,339.23
Jun 30, 2019 400,015.52
Dec 31, 2018 287,631.90
Dec 31, 2017 301,422.73
Jun 30, 2017 268,290.03
Dec 31, 2016 1.24 Mn